News | October 17, 2023
Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Lupin has received US$ 25 million from AbbVie for initiation of Phase 1 clinical studies successfully
Oncodesign Services and ImaginAb sign a Preclinical License and Supply Agreement
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
